top of page

TILs - Case Studies

Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges

Zhao Y, Deng J, Rao S, Guo S, Shen J, Du F, Wu X, Chen Y, Li M, Chen M, Li X, Li W, Gu L, Sun Y, Zhang Z, Wen Q, Xiao Z, Li J.
Cancers (Basel). 2022 Aug 27;14(17):4160

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

Maartje W. Rohaan, M.D., et al.

N Engl J Med 2022; 387:2113-2125

​

"In patients with advanced melanoma, progression-free survival was significantly longer among those who received TIL therapy than among those who received ipilimumab"

Publications - cell therapy: Files

Tumor Organoids - Case Studies

Tumor organoids: applications in cancer modeling and potentials in precision medicine

Xu, H., Jiao, D., Liu, A.
J Hematol Oncol 15, 58 (2022).

Patient-Derived Organoids for Precision Cancer Immunotherapy

M. Grönholm, M. Feodoroff, G. Antignani, B. Martins, F. Hamdan, V. Cerullo 
Cancer Res (2021) 81 (12): 3149–3155

Publications - cell therapy: Files
bottom of page